Fox Chase Cancer Center’s Dr. Mary Daly Receives Inaugural Impact Award From Basser Center for BRCAMay 31st 2023
Fox Chase Cancer Center’s Mary Daly, MD, PhD, FACP was recently recognized as the first recipient of the BRCA Impact Award from Penn Medicine’s Basser Center for BRCA.
Latinx Patients Highlight Barriers to Tumor Genomic Profiling for CancerMay 29th 2023
Latinx patients with cancer had a low rate of tumor genomic profiling, partially due to structural and cultural barriers, according to findings from a qualitative study presented during the 5th Annual Regional SPEECH Conference and Retreat.
Liver Cancer Awareness Higher in Individuals Who Receive HBV/HCV ScreeningMay 26th 2023
Individuals in Philadelphia and New York City who were screened for the common liver cancer risk factors hepatitis B virus or hepatitis C virus displayed a higher level of knowledge of liver cancer.
Fox Chase Physician Wins Best Poster Award at Breast Cancer Meeting for Research on Surgery to Remove Lymph NodesMay 26th 2023
Austin D. Williams, MD, MSEd, of Fox Chase Cancer Center, received the Best Poster Award at the recent 24th Annual Meeting of the American Society of Breast Surgeons.
SPEECH Conference Highlights Multiplicity of Ongoing Efforts in Cancer Care EquityMay 23rd 2023
Young investigators, fellows, and medical students recently gathered at the Temple University Lewis Katz School of Medicine in Philadelphia, Pennsylvania, to network and share exciting research aimed at addressing disparities in the dissemination of cancer care at the 5th Annual Regional Synergistic Partnership for Enhancing Equity in Cancer Health Conference and Retreat.
Lewis Katz School of Medicine’s Dr. Matthew Lee Discusses Experience With New Robotic Laparoscopic Procedure at 2023 AUA Annual MeetingMay 12th 2023
Matthew Lee, MD, MBA, discusses his use of a new robotic laparoscopic procedure to treat a complication caused by cancer radiation therapy at the 2023 American Urological Association Annual Meeting.
Stand Up to Cancer Grant Recipients Discuss Initiative to Expand Access to Early-Phase Clinical TrialsMay 1st 2023
Faculty across 4 institutions discuss their participation in a 4-team initiative launched by Stand Up To Cancer® that focuses on expanding access to cancer care and research.
Researcher at Lewis Katz School of Medicine and Fox Chase Wins $800,000 Grant for Work on Childhood CancersMay 1st 2023
Christian Hurtz, PhD, an assistant professor at the Fels Cancer Institute for Personalized Medicine at the Lewis Katz School of Medicine at Temple University, has been awarded a four-year $800,000 A-Award by Alex’s Lemonade Stand Foundation for Childhood Cancer.
Fox Chase Cancer Center’s Edna ‘Eti’ Cukierman Appointed Chair-Elect of the American Association for Cancer Research’s Tumor Microenvironment Working GroupApril 25th 2023
Edna “Eti” Cukierman, PhD, was been appointed chair-elect of the AACR Tumor Microenvironment Working Group at the AACR Annual Meeting 2023.
Fox Chase Cancer Center Clinical Director Wins Oncology Nursing Society’s Excellence in Cancer Nursing Management AwardApril 21st 2023
Erin Longstreth-Papsun, RN, MSN, OCN, NEA-BC, clinical director of Ambulatory Satellite Clinics and Radiation Oncology Nursing at Fox Chase Cancer Center, was recently awarded the Excellence in Cancer Nursing Management Award by the Oncology Nursing Society (ONS).
Drs Edelman and Fleisher on Personalizing and Adapting Treatment Approaches in Clinical TrialsMarch 17th 2023
Martin Edelman, MD, and Linda Fleisher, PhD, MPH, discuss their role within the Stand Up To Cancer® 4-team initiative, focusing on diversity in early-phase clinical trials.
DNA Methylation Makes Cancer Cells More Vulnerable to Immune Response, Fox Chase Cancer Center Study ShowsMarch 17th 2023
A new study by Fox Chase Cancer Center scientists shows how DNA methylation can regulate the immune response in colorectal cancer, laying the groundwork for potential new treatments. .
Fox Chase Cancer Center Researchers Open Clinical Trial That Could Help Men Avoid Surgery to Remove ProstateMarch 15th 2023
Researchers at Fox Chase Cancer Center have begun recruiting for a clinical trial called PRESERVE that will evaluate the safety and efficacy of the NanoKnife System to treat patients with intermediate-risk prostate cancer.
Fox Chase Researchers Receive $1 Million Grant to Develop Platform That Could Assist in Development of New DrugsMarch 3rd 2023
John Karanicolas, PhD, co-leader of the Cancer Signaling and Microenvironment research program at Fox Chase Cancer Center, was recently awarded a $1 million grant from the W.M. Keck Foundation to develop a platform that could assist in the development of new drugs.
Fox Chase’s Cihangir Duy Receives an American Society of Hematology 2023 Scholar AwardFebruary 17th 2023
Cihangir Duy, PhD, MS, an assistant professor in the Nuclear Dynamics and Cancer research program and a member of the Cancer Epigenetics Institute at Fox Chase Cancer Center, has been awarded an American Society of Hematology 2023 Junior Faculty Scholar Award in basic/translational research.
Fox Chase Cancer Center Researchers Receive Grant to Address Diversity in Early Development Clinical TrialsFebruary 14th 2023
Researchers at Fox Chase Cancer Center were recently awarded a $550,000 grant from Stand Up To Cancer (SU2C) to fund a new project, “Accelerating and Diversifying Access to Clinical Trials.”
Two Fox Chase Clinicians Named to 2022 List of World’s Most Highly Cited ResearchersFebruary 6th 2023
Fox Chase Cancer Center physicians Hossein Borghaei, DO, MS, and Elizabeth Plimack, MD, MS, have been named to the 2022 list of Highly Cited Researchers by Clarivate.
Fox Chase Cancer Center Review Distills Current Research on Kidney Cancer Epidemiology and Risk FactorsFebruary 3rd 2023
To synthesize advancements in the detection, treatment, and prevention of kidney cancer and summarize their effects globally, Fox Chase Cancer Center Urologic Oncology Fellow Laura Bukavina, MD, MPH, spearheaded a recent review on the topic.
The Lewis Katz School of Medicine at Temple University and Fox Chase Cancer Center Welcome Lucia BorrielloJanuary 19th 2023
The Lewis Katz School of Medicine at Temple University and Fox Chase Cancer Center are pleased to announce the hiring of Lucia Borriello, PhD, as an assistant professor in the Department of Cancer and Cellular Biology at Temple.
Fox Chase Cancer Center President and CEO Dr. Robert Uzzo Presents Rhoads Oration for Philadelphia Academy of SurgeryJanuary 6th 2023
Joining a list of over 100 previous orators, Robert Uzzo, MD, MBA, FACS, president and CEO of Fox Chase Cancer Center, delivered the Rhoads Oration for the Philadelphia Academy of Surgery this month at The College of Physicians of Philadelphia.
Fox Chase Graduate Student Billy Truong Recognized With ASH Abstract Achievement AwardDecember 19th 2022
Billy Truong, a doctoral candidate at Fox Chase Cancer Center, was awarded the American Society of Hematology Abstract Achievement Award for a poster that he presented at the 64th ASH Annual Meeting and Exposition.